Western Blotting Market Size, Share & Trends Analysis By Product, By Applications, By End Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global Western Blotting Market is projected to be worth USD 1.6 billion by 2030
According to SPER Market Research, the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS worldwide, increase funding in biomedical sector, and shift towards personalized medicine, technological advancements; are the growths driving factors.
Impact of COVID-19 on the the Western Blotting Market
Because of the increased awareness about the infection, research work also increased. Due to COVID-19 epidemic, testing, diagnosing of the infection increased by the companies. That leads to huge opportunities for companies to make profits.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Application, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, Latin America , and MEA
Companies Covered
Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific
Driver: Technological advancements
Rising incidences of HIV/AIDS globally gave impetus for the advancement and up gradation of technologies, there increased demand for personalized medicine in turn funding of government in Biomedical Research, these are the key elements for the growth of this market.
Restraint: Emergence of alternative technologies
Alternative technologies (ELISA, LC/MS, and LFIA) are user friendly, high accuracy, Precision, high speed, consistency, sensitivity, and can handle multiple samples as compared to existing technologies (Western Blotting).
Challenges: Requirement of high procedural efficiency for accurate results
To get a reliable, quantitative result there is need of high efficiency, precise methodology, analytical knowledge, widespread labour-intensive managing, handiness, and firm observance of protocols. The data variations & Failure rates are high in Western Blotting.
Opportunity: Emerging economies
There will be huge opportunities in the Asia Pacific, Latin America, the Middle East & Africa, due to increasing the innovation in the research & development, health care market, personalized medicine, developments in research infrastructure and the economical manufacturing cost of emerging APAC countries encourage market players to invest.
Global Western Blotting Market, by Product:
Based upon the product, the Global western blotting market is segmented as; Consumables (Reagents & Buffers, Antibodies & Conjugates, Kits, Membranes & Filter Papers, Other Consumables), Instruments {Electrophoresis Instruments, Blotting Systems, Imagers (Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers)}.
Global Western Blotting Market, by Application:
Based upon the Application, the Global western blotting market is segmented as; Biomedical Research, Clinical Diagnostics (Hepatitis, HIV, Lyme disease, Other Diseases), Agricultural Applications, Other Applications
Global Western Blotting Market, by End Users
Based upon the End Users, the Global western blotting market is segmented as; Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users.
Global Western Blotting Market, by Region:
North America dominates the highest share of this market, is due to the presence of big companies, increase in investment in biomedical research, and demand for personalized medicine.
According to SPER Market Research, the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS worldwide, increase funding in biomedical sector, and shift towards personalized medicine, technological advancements; are the growths driving factors.
Impact of COVID-19 on the the Western Blotting Market
Because of the increased awareness about the infection, research work also increased. Due to COVID-19 epidemic, testing, diagnosing of the infection increased by the companies. That leads to huge opportunities for companies to make profits.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Application, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, Latin America , and MEA
Companies Covered
Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific
Driver: Technological advancements
Rising incidences of HIV/AIDS globally gave impetus for the advancement and up gradation of technologies, there increased demand for personalized medicine in turn funding of government in Biomedical Research, these are the key elements for the growth of this market.
Restraint: Emergence of alternative technologies
Alternative technologies (ELISA, LC/MS, and LFIA) are user friendly, high accuracy, Precision, high speed, consistency, sensitivity, and can handle multiple samples as compared to existing technologies (Western Blotting).
Challenges: Requirement of high procedural efficiency for accurate results
To get a reliable, quantitative result there is need of high efficiency, precise methodology, analytical knowledge, widespread labour-intensive managing, handiness, and firm observance of protocols. The data variations & Failure rates are high in Western Blotting.
Opportunity: Emerging economies
There will be huge opportunities in the Asia Pacific, Latin America, the Middle East & Africa, due to increasing the innovation in the research & development, health care market, personalized medicine, developments in research infrastructure and the economical manufacturing cost of emerging APAC countries encourage market players to invest.
Global Western Blotting Market, by Product:
Based upon the product, the Global western blotting market is segmented as; Consumables (Reagents & Buffers, Antibodies & Conjugates, Kits, Membranes & Filter Papers, Other Consumables), Instruments {Electrophoresis Instruments, Blotting Systems, Imagers (Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers)}.
Global Western Blotting Market, by Application:
Based upon the Application, the Global western blotting market is segmented as; Biomedical Research, Clinical Diagnostics (Hepatitis, HIV, Lyme disease, Other Diseases), Agricultural Applications, Other Applications
Global Western Blotting Market, by End Users
Based upon the End Users, the Global western blotting market is segmented as; Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users.
Global Western Blotting Market, by Region:
North America dominates the highest share of this market, is due to the presence of big companies, increase in investment in biomedical research, and demand for personalized medicine.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Western Blotting Market
4.4. Market Trends
5. GLOBAL WESTERN BLOTTING MARKET, BY PRODUCT TYPE, 2019-2030 (USD MILLION)
5.1. Consumables
5.1.1. Antibodies & Conjugates
5.1.2. Kits
5.1.3. Membranes & Filter Papers
5.1.4. Other Consumables
5.1.5. Reagents & Buffers
5.2. Instruments
5.2.1. Electrophoresis Instruments
5.2.2. Blotting Systems
5.2.3. Imagers
5.2.3.1. Chemiluminescent Imagers
5.2.3.2. Fluorescent Imagers
5.2.3.3. Other Imagers
6. GLOBAL WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Agricultural Applications
6.2. Biomedical Research
6.3. Clinical Diagnostics
6.3.1. Hepatitis
6.3.2. HIV
6.3.3. Lyme disease
6.3.4. Other Diseases
6.4. Other Applications
7. GLOBAL WESTERN BLOTTING MARKET, BY END USERS, 2019-2030 (USD MILLION)
7.1. Academic & Research Institutes
7.2. Biopharmaceutical & Biotechnology Companies
7.3. Hospitals & Diagnostic Laboratories
7.4. Other End Users
8. GLOBAL WESTERN BLOTTING MARKET, BY REGION, 2019-2030 (USD MILLION)
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. The middle East
8.6. Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Bio-Rad Laboratories, Inc.
10.2. Bio-Techne Corporation
10.3. Danaher Corporation
10.4. Merck KGaA
10.5. Thermo Fisher Scientific
11. APPENDIX
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Western Blotting Market
4.4. Market Trends
5. GLOBAL WESTERN BLOTTING MARKET, BY PRODUCT TYPE, 2019-2030 (USD MILLION)
5.1. Consumables
5.1.1. Antibodies & Conjugates
5.1.2. Kits
5.1.3. Membranes & Filter Papers
5.1.4. Other Consumables
5.1.5. Reagents & Buffers
5.2. Instruments
5.2.1. Electrophoresis Instruments
5.2.2. Blotting Systems
5.2.3. Imagers
5.2.3.1. Chemiluminescent Imagers
5.2.3.2. Fluorescent Imagers
5.2.3.3. Other Imagers
6. GLOBAL WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Agricultural Applications
6.2. Biomedical Research
6.3. Clinical Diagnostics
6.3.1. Hepatitis
6.3.2. HIV
6.3.3. Lyme disease
6.3.4. Other Diseases
6.4. Other Applications
7. GLOBAL WESTERN BLOTTING MARKET, BY END USERS, 2019-2030 (USD MILLION)
7.1. Academic & Research Institutes
7.2. Biopharmaceutical & Biotechnology Companies
7.3. Hospitals & Diagnostic Laboratories
7.4. Other End Users
8. GLOBAL WESTERN BLOTTING MARKET, BY REGION, 2019-2030 (USD MILLION)
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. The middle East
8.6. Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Bio-Rad Laboratories, Inc.
10.2. Bio-Techne Corporation
10.3. Danaher Corporation
10.4. Merck KGaA
10.5. Thermo Fisher Scientific
11. APPENDIX
